New long-term studying in prevention of a migraine shows, that patients who accepted treatment Topamax (R) (topiramate) for preventive maintenance of a migraine about one year, have tested the maintained reduction quantity of days of a migraine in a month, with the essential connected benefits on quality of a life. Studying also has shown, that there was an essential increase in quantity of monthly days of a migraine after the termination topiramate.

Migraine - very often disease, 11 % of adult population touching approximately in the world, one American studying has estimated, that 5.85 million person in the USA, in the age of 16-65 years some times in a month suffer attributes of disease.

Research proceeded 12 months to investigate long efficiency topiramate in reduction of quantity of days of a migraine later six months, in comparison with influence of the termination of treatment after six months. All patients have received open package Topamax within the first 6 months, and then group have divided to continue one treatment Topamax, and to anothers have suggested placebo for truthfulness of study.

After 6 months of treatment topiramate on the average, the quantity of monthly days of a migraine has fallen considerably from 9.12 till 6.02;

After 12 months, reduction of average quantity of monthly days of a migraine on has taken place, as it happened within first six months of treatment and remained almost constant in group which continued to accept on topiramate. However, patients who have been switched to placebo in six months, have tested essential increase in quantity of days of a migraine, with average increase it is more than 1 day of a migraine in a month.

One of the majority of aspects of lacks of a migraine - wearisome influence which it has on the patient and their lives: their abilities to make their work properly or even to enjoy a life and actions of leisure. That reduces this effect and allows people to live with a migraine a high-grade life highly is welcomed.